Source link : https://newshealth.biz/health-news/blood-cell-patterns-predict-poor-venetoclax-response/
TOPLINE: Erythroid-predominant myelodysplastic neoplasms (EP MDS) (18%) exhibit unique genomic features with frequent TP53 mutations and distinct survival patterns. These cases show poor outcomes with venetoclax therapy due to BCL-XL dependence rather than BCL2, suggesting the need for alternative treatment strategies. METHODOLOGY: Researchers evaluated 371 consecutive patients with newly diagnosed MDS presenting between December 2016 […]
The post Blood Cell Patterns Predict Poor Venetoclax Response first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-11 05:40:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8